{"changes":[],"country":"US","description":"HeartPoint Global is developing the HPGS, a minimally invasive adjustable percutaneous device that replaces surgical pulmonary artery banding for paediatric and adult heart-failure patients. It targets congenital heart-defect and CHF cases especially in low- and middle-income markets where open surgery is harder to access. The implant allows post-procedure pressure adjustment without re-operation.","domain":"heartpointglobal.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":[],"lat":25.73311,"lng":-80.258511,"location":"coral gables, fl, usa","name":"HeartPoint Global Inc.","rounds":[{"amountQuarantined":false,"amountUsd":1800000,"currency":"USD","date":"2025-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"heartpointglobal-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"heartpointglobal.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://heartpointglobal.com"},{"fact":"description","publisher":"heartpointglobal.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://heartpointglobal.com"}],"stage":null,"techStack":["Cloudflare","WordPress 6.9.4","Mesmerize Companion 1.6.173","MonsterInsights 10.2.0","reCAPTCHA","Google Analytics","Google Tag Manager","jQuery Migrate 3.4.1","imagesLoaded 2.10.1.5","ExtendThemes Mesmerize","DoubleClick Floodlight","Cloudflare Bot Management"],"totalRaisedUsd":1800000,"updatedAt":"2026-05-05"}